SureTrader SureTrader SureTrader
Home > Boards > US Listed > Biotechs > Ariad Pharmaceuticals, Inc. (ARIA)

Buyout by Pfizer...???

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Storage33 Member Profile
 
Followed By 3
Posts 159
Boards Moderated 0
Alias Born 11/08/12
160x600 placeholder
Written Communication Relating to an Issuer or Third Party (sc To-c) "Edgar (US Regulatory)" - 1/11/2017 5:24:26 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/10/2017 6:18:41 PM
Written Communication Relating to an Issuer or Third Party (sc To-c) "Edgar (US Regulatory)" - 1/10/2017 5:30:12 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/10/2017 3:06:07 PM
Amended Statement of Beneficial Ownership (sc 13d/a) "Edgar (US Regulatory)" - 1/10/2017 8:13:52 AM
Written Communication Relating to an Issuer or Third Party (sc To-c) "Edgar (US Regulatory)" - 1/9/2017 5:13:19 PM
Harwood Feffer LLP Announces Investigation of ARIAD Pharmaceuticals, Inc. "PR Newswire (US)" - 1/9/2017 5:05:00 PM
Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) "Edgar (US Regulatory)" - 1/9/2017 4:38:49 PM
Rigrodsky & Long, P.A. Announces Investigation Of Buyout "Business Wire" - 1/9/2017 12:46:00 PM
ARIAD Enters into Definitive Agreement to Be Acquired by Takeda for $5.2 Billion "Business Wire" - 1/9/2017 8:02:00 AM
Takeda to Acquire ARIAD Pharmaceuticals, Inc. "Business Wire" - 1/9/2017 8:00:00 AM
ARIAD to Present at the 35th Annual J.P. Morgan Healthcare Conference "Business Wire" - 1/3/2017 7:35:00 AM
Traders News Issues New Reports and Features a New OTCQB Company Profile "InvestorsHub NewsWire" - 12/13/2016 9:25:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/8/2016 8:01:52 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/7/2016 4:07:44 PM
ARIAD’s Investigational Medicine Brigatinib Demonstrated 15.6 Month Systemic Median Progression-Free Survival in ALTA Study "Business Wire" - 12/7/2016 7:35:00 AM
ARIAD Announces Data Presentations at American Society of Hematology Meeting "Business Wire" - 12/6/2016 7:35:00 AM
ARIAD Presents Updated Brigatinib Data with 18.4 Months Median Intracranial Progression Free Survival (PFS) in ALK+ NSCLC Pat... "Business Wire" - 12/5/2016 7:35:00 AM
ARIAD to Host Webcast and Conference Call on Brigatinib Data Presentations at the World Conference on Lung Cancer "Business Wire" - 12/2/2016 4:05:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/30/2016 4:06:56 PM
ARIAD Announces FDA Full Approval & Label Update for Iclusig® (ponatinib) Based on Long-Term Efficacy & Safety Data from Pha... "Business Wire" - 11/29/2016 7:35:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/18/2016 4:07:44 PM
ARIAD Announces Data Presentations at the World Conference on Lung Cancer "Business Wire" - 11/16/2016 5:04:00 PM
ARIAD Announces Launch of Inaugural ALK+ Day During Lung Cancer Awareness Month "Business Wire" - 11/14/2016 7:35:00 AM
ARIAD Announces Phase 1/2 Trial Data on Investigational Drug Brigatinib Published in The Lancet Oncology "Business Wire" - 11/9/2016 7:35:00 AM
Storage33   Monday, 12/23/13 02:36:36 PM
Re: None
Post # of 80302 
Buyout by Pfizer...???
16$ in Jan


SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist